New Trial CABOGIST now open

Cabozantinib in patients with metastatic gastrointestinal stromal tumor (GIST) who progressed during neoadjuvant, adjuvant or palliative therapy with imatinib and sunitinib.

Trial name: CABO-GIST (see more information on our study registry)

Agents: Cabozantinib

Phase: II

Status: Open, recruiting

Sponsor: European Organisation for Research and Treatment of Cancer – EORTC

Further information https://clinicaltrials.gov/ct/show/NCT02216578 or http://www.eortc.org/clinical-trials/